Inspiration
The inspiration for Rabtik-11 stems from a critical gap in regenerative medicine: the lack of continuous, specialized monitoring for chronic wounds and severe skin conditions. As a biochemistry professional, I witnessed how static treatments fail to adapt to the unique biological pace of each patient. We wanted to create a "living" treatment that thinks and evolves alongside the patient's recovery.
What it does
Rabtik-11 is a bio-adaptive ecosystem that combines a proprietary regenerative topical formula with a clinical AI agent powered by Gemini 1.5 Pro.
Multimodal Analysis: Patients upload photos of their recovery process.
Autonomous Diagnosis: Gemini's vision capabilities analyze tissue regeneration, identifying patterns invisible to the naked eye.
Adaptive Protocols: The system automatically adjusts the treatment plan based on real-time biochemical progress.
How we built it
The project is built on a dual foundation of Advanced Biochemistry and Generative AI:
Biochemical Core: Developed through rigorous research in tissue regeneration and ozonation processes.
AI Integration: Leveraging Gemini's API to process multimodal data (images and clinical text).
Business Structure: Operated by RAB Medical Solutions SpA, ensuring a scalable and legally sound clinical solution.
Challenges we ran into
One of the biggest challenges has been ensuring the accuracy of AI vision in varied lighting and skin tones. We are also navigating the complex regulatory landscape for bio-pharmaceutical products to ensure full compliance while maintaining the speed of AI innovation.
Accomplishments that we're proud of
We are proud of successfully stabilizing the Rabtik-11 formula and conceptualizing an AI agent that doesn't just provide data, but understands the biological context of healing. Forming Inversiones BAT SpA marks our commitment to turning this scientific breakthrough into a real-world business.
What we learned
We learned that the fusion of "Bits and Atoms"—software and biochemistry—is the future of medicine. Gemini has shown us that AI can be a powerful ally in identifying microscopic healing trends that were previously overlooked.
What's next for Rabtik-11: Bio-Adaptive Regenerative System
Our next goal is to finalize clinical testing in partnership with laboratories like Bellcos and integrate our Gemini-based agent into a mobile platform for global distribution.
Log in or sign up for Devpost to join the conversation.